Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review

Premenstrual syndrome and its most severe form, premenstrual dysphoric disorder (PMDD), are two well-defined clinical entities that affect a considerable number of women. Progesterone metabolites and certain neurotransmitters, such as gamma-aminobutyric acid and serotonin, are involved in the etiolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lete, Iñaki, Lapuente, Oihane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683150/
https://www.ncbi.nlm.nih.gov/pubmed/29386943
http://dx.doi.org/10.2147/OAJC.S97013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683150/
https://www.ncbi.nlm.nih.gov/pubmed/29386943
http://dx.doi.org/10.2147/OAJC.S97013

Ejemplares similares